Biggest News Aggregation in the World
📰 Peter Greenleaf News

Page 4 - Peter Greenleaf News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Peter Greenleaf. Real-time updates on events, politics, business and more.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Receives $12.33 Average PT from Brokerages

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) has earned an average recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target […]
United States Josephm Miller Peter Greenleaf Great West Life Assurance Co Aurinia Pharmaceuticals Stock Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 3.8%

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) was down 3.8% on Monday . The stock traded as low as $9.42 and last traded at $9.49. Approximately 304,420 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 3,458,650 shares. The stock had previously closed at $9.86. Wall Street […]
United States Peter Greenleaf Georgem Milne Jr Squarepoint Ops Aurinia Pharmaceuticals Hedge Funds Weigh In On Aurinia Pharmaceuticals
Source: wkrb13.com

Aurinia Pharmaceuticals (NASDAQ:AUPH) Trading Up 4.8%

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP)’s stock price was up 4.8% during mid-day trading on Wednesday . The stock traded as high as $10.74 and last traded at $10.64. Approximately 860,249 shares were traded during trading, a decline of 75% from the average daily volume of 3,486,144 shares. The stock had previously closed […]
United States Peter Greenleaf Georgem Milne Jr Legacy Advisors Securities Exchange Commission Aurinia Pharmaceuticals Inc
Source: wkrb13.com

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Given Average Rating of "Moderate Buy" by Brokerages

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) has been assigned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price target […]
Nova Scotia United States Josephm Miller Peter Greenleaf News Ratings For Aurinia Pharmaceuticals Daily Aurinia Pharmaceuticals Stock Down

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 2.5%

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP)’s stock price traded up 2.5% on Friday . The company traded as high as $9.69 and last traded at $9.52. 793,227 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 3,353,056 shares. The stock had previously closed at $9.29. Analysts […]
United States Peter Greenleaf Josephm Miller Insider Activity At Aurinia Pharmaceuticals News Ratings For Aurinia Pharmaceuticals Daily Lazard Asset Management
Source: wkrb13.com

StockNews.com Initiates Coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH)

Analysts at StockNews.com initiated coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, Royal Bank of Canada reissued an “outperform” rating and issued a $11.00 price objective on shares of […]
United States Peter Greenleaf Josephm Miller Tang Capital Management Analyst Recommendations For Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc

Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results

03.11.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the three months ended September 30, 2022. Amounts, unless specified otherwise, are expressed in U.S. dollars. Total net revenue was $55.8 ...
United States United Kingdom Northern Ireland Peter Greenleaf Otsuka Pharmaceuticals Co Ltd Sun Pharmaceuticals

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science